Changes (95% CI) in CD4 cell count at viral set-point (cells/mm3) using different models.

aHomogeneous patient group: MSM from W-Europe/N-America. Patients with non-B subtype infection excluded.bAdjusted for gender, region of origin, subtype, age at seroconversion, HIV transmission group, interval between seroconversion and viral set-point, and presence of a resistance mutation.a 同质患者队列：来自西欧（Western Europe）与北美（North America）的男男性行为者（Men who have sex with men，MSM），排除感染非B亚型病毒的患者。b 已针对性别、原籍地区、病毒亚型、血清转换时年龄、HIV传播途径、血清转换至病毒设定点的间隔时长以及耐药突变的存在情况进行校正。